Views of Wall Street’s Leading Experts on Hims & Hers Health Inc

With 2.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.87 shares. The 52-week range on HIMS shows that it touched its highest point at $12.34 and its lowest point at $5.65 during that stretch. It currently has a 1-year price target of $10.45. Beta for the stock currently stands at 0.79.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIMS was up-trending over the past week, with a rise of 11.27%, but this was up by 14.37% over a month. Three-month performance surged to 40.60% while six-month performance rose 37.27%. The stock gained 17.08% in the past year, while it has gained 10.90% so far this year. A look at the trailing 12-month EPS for HIMS yields -0.17 with Next year EPS estimates of -0.06. For the next quarter, that number is -0.02. This implies an EPS growth rate of 58.77% for this year and 57.18% for next year.

Float and Shares Shorts:

At present, 200.05 million HIMS shares are outstanding with a float of 135.89 million shares on hand for trading. On Jan 31, 2024, short shares totaled 14.42 million, which was 6.80% higher than short shares on Dec 29, 2023. In addition to Mr. Andrew Dudum as the firm’s Co-Founder, Chairman & CEO, Mr. Yemi Okupe serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 63.81% of HIMS’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIMS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HIMS analysts setting a high price target of $15.00 and a low target of $7.00, the average target price over the next 12 months is $10.45. Based on these targets, HIMS could surge 51.98% to reach the target high and fall by -29.08% to reach the target low. Reaching the average price target will result in a growth of 5.88% from current levels.

Summary of Insider Activity:

Insiders traded HIMS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 74 while that of sell transactions has risen to 102 over the past year. The total number of shares bought during that period was 3,221,587 while 12,716,050 shares were sold.